Prostate Cancer - Results from #60

Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration. September 1, 2021

Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial. September 1, 2021

Male circumcision and prostate cancer: a meta-analysis revisited. September 1, 2021

Adherence with protocol medication use and mortality from unrelated causes in a prevention trial. August 31, 2021

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study. August 31, 2021

Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. August 31, 2021

Individual patient data meta-analysis of discrimination of the four kallikrein panel associated with the inclusion of prostate volume. August 31, 2021

Long-term survival after LDR Brachytherapy for Prostate Cancer: the Royal Surrey experience. August 31, 2021

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response. August 30, 2021

The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer. August 30, 2021

The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy. August 30, 2021

Why Does MRI-Targeted Biopsy Miss Clinically Significant Cancer? August 30, 2021

Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection. August 27, 2021

Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort. August 27, 2021

Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. August 27, 2021

Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice. August 27, 2021

The Prostate Cancer Foundation Appoints Charles J. Ryan, MD, as President and Chief Executive Officer August 26, 2021

PSA: Declining utilization of prostate brachytherapy. August 26, 2021

Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival. August 26, 2021

T2-PROPELLER Compared to T2-FRFSE for Image Quality and Lesion Detection at Prostate MRI. August 26, 2021

Page 4 of 1173